R

Revolo Biotherapeutics

25 employees

Revolo Biotherapeutics has developed therapies that achieve superior long-term disease remission from less frequent chronic dosing.

Basic info

Industry

biotechnology
biotechnology research

Sectors

Biotechnology
Health Care
Life Science

Date founded

2011

Funding rounds raised

Total raised

$52M

from 3 investors over 3 rounds

R

Revolo Biotherapeutics raised $52M on September 21, 2020

Investors: Metellus AG, 24Haymarket and Morningside Venture Capital 晨兴资本

FAQ